Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Aiello Joshua. Director active across 1 company, notably Orchestra BioMed Holdings, Inc.. Aggregated, 8 disclosures have been recorded. History available since 20 July 2023. The latest transaction was disclosed on 26 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Aiello Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
203 shares@ US$5.26Common Stock, par value $0.0001 per shareSEC:0001104659-26-103205:0
241 shares@ US$4.5730.6% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-036167:0
241 shares@ US$4.3120.1% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-000271:0
203 shares@ US$2.4612.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-091745:0
15,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075779:0
393 shares@ US$2.9947.6% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-061170:0
278 shares@ US$4.38100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-25-029494:0
5,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083497:0
About Aiello Joshua
Aiello Joshua is an insider associated with Orchestra BioMed Holdings, Inc., where he serves as Principal Accounting Officer. He has 7 filings in total, and the recent filings we track cover the period from 2023-07-24 to 2026-03-27. In those recent filings, the most frequent transaction nature is tax withholding, with individual amounts up to EUR 1128.7522261769.